Skip to content

Feasibility and Efficacy of a Brief Mindfulness-Based Intervention SMOKING INTERVENTION VIA THE INTERNET

Feasibility and Efficacy of a Brief Mindfulness-Based Smoking Intervention Via the Internet

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04572126
Enrollment
80
Registered
2020-10-01
Start date
2020-11-25
Completion date
2021-08-01
Last updated
2022-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Smoking Reduction, Substance Use

Keywords

Smoking Reduction

Brief summary

The current study will examine both the feasibility and efficacy of a single session, web-based mindfulness-based intervention for smoking cessation. The study will explore (1) participants' subjective experiences of the intervention, (2) cravings and negative affect both before and after the intervention, and (3) changes in tobacco use one week and one month following the initial intervention. Further, the study will examine how often participants utilize the intervention between the initial study and follow-up periods.

Interventions

BEHAVIORALMindfulness Intervention

The mindfulness intervention includes strategies to cope with substance cravings based on previously published mindfulness techniques. Examples of strategies presented include paying close attention to sensations, acceptance of cravings, and self-kindness.

BEHAVIORALControl Intervention

The control intervention instructs participants to utilize their own, previously used strategies to cope with substance cravings.

Sponsors

Wayne State University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Intervention model description

Participants are randomly assigned to either the mindfulness intervention group or control group.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Daily Smoker * Has a desire to quit or reduce smoking. * Is not currently involved in another smoking reduction or cessation program.

Exclusion criteria

\-

Design outcomes

Primary

MeasureTime frameDescription
Subjective Ratings QuestionnaireImmediately post-interventionThe participant's ratings of subjective likeability and helpfulness of the intervention. These ratings will be measured on a 5-point Likert Scale with higher scores representing more likeability and helpfulness. The 11-item questionnaire results in a score ranging from 11-55.
Change in Past Month Cigarette and E-Cigarette use.Immediately before the intervention and at one-month follow-up.An online version of the TLFB (Sobbel & Sobbel, 1992) will be used to measure past-month cigarette and e-cigarette use. The measure will be administered pre-intervention and one-month following the intervention to show change over time.
Change in Cigarette/E-cigarette CravingImmediately preceding and following intervention.Craving to smoke will be measured using the 10-item Brief Questionnaire of Smoking Urges (Cox, Tiffany, & Christen, 2001).While the QSU-brief can be scored by using all 10 items for one total craving score, maximum likelihood factor analysis of the QSU-brief revealed a two-factor model consisting of (1) a strong desire and intention to smoke with the perception of receiving positive rewards from smoking and (2) the expectation that smoking would relieve negative affect and the strong desire to smoke. The measure will be administered immediately preceding and following the intervention to show intervention influence on craving.
Change in Positive and Negative AffectImmediately preceding and following intervention as well as at one-month follow-up.Positive and negative affect will be measured by the Positive and Negative Affect Schedule (Watson & Clark, 1999).

Secondary

MeasureTime frameDescription
Intervention Use.One-month after intervention.Number of times participants viewed intervention between intervention completion and one-month follow-up.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026